Institutional investors hold a majority ownership of AGN through the 85.85% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2017, these large investors purchased a net $5.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HENDERSON GLOBAL INVESTORS LTD. Bought 4.9 Million shares of Allergan
MANULIFE ASSET MANAGEMENT (US) L... Bought 1.6 Million shares of Allergan
JPMORGAN INVESTMENT MANAGEMENT, ... Bought 1.2 Million shares of Allergan